Ads

You May Also Like

Innovation Pharmaceuticals Opens New Clinical Site for Novel p53 Drug Candidate in Phase 2 Ovarian Cancer Trial

BEVERLY, Mass., Sept. 14, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals Inc., (OTCQB:IPIX) (“the Company”), ...

Celsion Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results

Celsion Enters 2018 with Solid Fundamentals, a Strong Balance Sheet and            an Advancing Clinical Pipeline ...